miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia

Area of Science:

• Cardiovascular Biology
• Molecular Biology
• Cell Biology

Background:

• Pulmonary arterial hypertension (PAH) pathogenesis involves microRNAs (miRNAs).
• Hypoxia is a key stimulus for pulmonary artery smooth muscle cell proliferation and PAH development.
• The specific miRNAs and pathways involved in hypoxia-induced PAH remain unclear.

Purpose of the Study:

• To identify key miRNAs regulated by hypoxia in human pulmonary artery smooth muscle cells (HPASMC).
• To elucidate the role of hypoxia-induced miRNAs in the pathogenesis of pulmonary arterial hypertension.
• To investigate the molecular mechanisms underlying hypoxia-mediated miRNA regulation and function in HPASMC.

Main Methods:

• miRNA microarray assays on hypoxia-treated and control HPASMC.
• Analysis of miR-210 expression in mouse models of chronic hypoxia-induced PAH.
• Assessment of hypoxia-inducible factor-1α (HIF-1α) dependency for miR-210 induction.
• Functional studies involving inhibition of miR-210 in HPASMC to evaluate effects on cell number and apoptosis.
• Identification of direct targets of miR-210 using molecular biology techniques.

Main Results:

• miR-210 was identified as the predominant miRNA induced by hypoxia in HPASMC.
• miR-210 induction by hypoxia was confirmed in vivo in mouse lungs with PAH.
• Transcriptional induction of miR-210 in HPASMC was dependent on hypoxia-inducible factor-1α.
• Inhibition of miR-210 led to decreased HPASMC number due to increased apoptosis.
• miR-210 mediates its antiapoptotic effects by directly repressing the expression of transcription factor E2F3.

Conclusions:

• miR-210 is a critical hypoxia-inducible miRNA in pulmonary vascular cells.
• miR-210 plays a protective role against apoptosis in pulmonary vascular smooth muscle cells under hypoxic conditions.
• The miR-210/E2F3 axis is a novel pathway involved in the cellular response to hypoxia in the context of PAH pathogenesis.